High mobility group box 1 is a novel substrate of dipeptidyl peptidase-IV
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High mobility group box 1 is a novel substrate of dipeptidyl peptidase-IV
Authors
Keywords
-
Journal
DIABETOLOGIA
Volume 55, Issue 1, Pages 236-244
Publisher
Springer Nature
Online
2011-06-07
DOI
10.1007/s00125-011-2213-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Expression and spatial heterogeneity of dipeptidyl peptidases in endothelial cells of conduct vessels and capillaries
- (2011) Veerle Matheeussen et al. BIOLOGICAL CHEMISTRY
- Incretin-Based Therapies for Type 2 Diabetes Mellitus: Properties, Functions, and Clinical Implications
- (2010) Michael A. Nauck AMERICAN JOURNAL OF MEDICINE
- Inhibition of dipeptidyl peptidase 4 regulates microvascular endothelial growth induced by inflammatory cytokines
- (2010) Wataru Takasawa et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Genetic Deletion or Pharmacological Inhibition of Dipeptidyl Peptidase-4 Improves Cardiovascular Outcomes After Myocardial Infarction in Mice
- (2010) M. Sauve et al. DIABETES
- The Oral Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Increases Circulating Endothelial Progenitor Cells in Patients With Type 2 Diabetes: Possible role of stromal-derived factor-1
- (2010) G. P. Fadini et al. DIABETES CARE
- Relationship between GLP-1 levels and dipeptidyl peptidase-4 activity in different glucose tolerance conditions
- (2010) L. Pala et al. DIABETIC MEDICINE
- Synergy between CD26/DPP-IV Inhibition and G-CSF Improves Cardiac Function after Acute Myocardial Infarction
- (2009) Marc-Michael Zaruba et al. Cell Stem Cell
- Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?
- (2009) Roger Yazbeck et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Ex Vivo Priming of Endothelial Progenitor Cells With SDF-1 Before Transplantation Could Increase Their Proangiogenic Potential
- (2008) Faouzia Zemani et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- DPP4 inhibitors for diabetes—What next?
- (2008) Anne-Marie Lambeir et al. BIOCHEMICAL PHARMACOLOGY
- Stromal cell-derived factors 1α and 1β, inflammatory protein-10 and interferon-inducible T cell chemo-attractant are novel substrates of dipeptidyl peptidase 8
- (2008) Katerina Ajami et al. FEBS LETTERS
- High-Mobility Group Box 1 Protein in Human and Murine Skin: Involvement in Wound Healing
- (2008) Stefania Straino et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Unknown
- (2008) John Klune et al. MOLECULAR MEDICINE
- Decreased dipeptidyl peptidase-IV activity and glucagon-like peptide-1(7-36)amide degradation in type 2 diabetic subjects
- (2007) Aine M. McKillop et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes
- (2007) Kazuo Nakamura et al. MICROVASCULAR RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search